Home › Interstitial Lung Diseases › Wisconsin
Interstitial Lung Diseases clinical trials in Wisconsin
4 studies for Interstitial Lung Diseases are looking for participants at sites in Wisconsin.
Cities in Wisconsin
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Wisconsin-Madison, Madison
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Wisconsin Hospital and Clinics, Madison
- Aurora St. Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University Hospital and UW Health Clinics, Madison
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.